These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21939943)

  • 1. Surgical candidacy and selection biases in nonemergent left main stenting: implications for observational studies.
    McNulty EJ; Ng W; Spertus JA; Zaroff JG; Yeh RW; Ren XM; Lundstrom RJ
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1020-7. PubMed ID: 21939943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?
    Yap CH; Yan BP; Akowuah E; Dinh DT; Smith JA; Shardey GC; Tatoulis J; Skillington PD; Newcomb A; Mohajeri M; Pick A; Seevanayagam S; Reid CM
    JACC Cardiovasc Interv; 2009 Aug; 2(8):758-64. PubMed ID: 19695544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).
    Frutkin AD; Lindsey JB; Mehta SK; House JA; Spertus JA; Cohen DJ; Rumsfeld JS; Marso SP;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):614-21. PubMed ID: 19628183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
    Serruys PW; Farooq V; Vranckx P; Girasis C; Brugaletta S; Garcia-Garcia HM; Holmes DR; Kappetein AP; Mack MJ; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Pereda P; Huang J; Morel MA; Van Es GA; Dawkins KD; Mohr FW; Steyerberg EW
    JACC Cardiovasc Interv; 2012 Jun; 5(6):606-17. PubMed ID: 22721655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention.
    Waldo SW; Secemsky EA; O'Brien C; Kennedy KF; Pomerantsev E; Sundt TM; McNulty EJ; Scirica BM; Yeh RW
    Circulation; 2014 Dec; 130(25):2295-301. PubMed ID: 25391519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.
    Brilakis ES; Rao SV; Banerjee S; Goldman S; Shunk KA; Holmes DR; Honeycutt E; Roe MT
    JACC Cardiovasc Interv; 2011 Aug; 4(8):844-50. PubMed ID: 21851896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.
    De Luca L; Altamura L; Corvo P; De Persio G; Ghini AS; Petrolini A; Aurigemma C; Tomai F
    Catheter Cardiovasc Interv; 2011 May; 77(6):765-72. PubMed ID: 21413124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
    Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
    JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous left main coronary disease treatment without on-site surgery back-up in patients with acute coronary syndromes: immediate and 2-year outcomes.
    Gagnor A; Tomassini F; Romagnoli E; Infantino V; Rosa Brusin MC; Maria C; Tripodi R; Sangiorgi G; Varbella F
    Catheter Cardiovasc Interv; 2012 May; 79(6):979-87. PubMed ID: 21735530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft.
    Capodanno D; Capranzano P; Di Salvo ME; Caggegi A; Tomasello D; Cincotta G; Miano M; Patané M; Tamburino C; Tolaro S; Patané L; Calafiore AM; Tamburino C
    JACC Cardiovasc Interv; 2009 Aug; 2(8):731-8. PubMed ID: 19695541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
    Head SJ; Holmes DR; Mack MJ; Serruys PW; Mohr FW; Morice MC; Colombo A; Kappetein AP;
    JACC Cardiovasc Interv; 2012 Jun; 5(6):618-25. PubMed ID: 22721656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic function.
    Bollati M; Gerasimou A; Sillano D; Biondi-Zoccai G; Garrone P; Moretti C; Sciuto F; Omedé P; Trevi GP; Sheiban I
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):586-93. PubMed ID: 20088012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable long-term survival in patients undergoing stent PCI of unprotected left main coronary artery compared to predicted short-term prognosis of CABG estimated by EuroSCORE: clinical determinants of long-term outcome.
    Lehmann R; Spyridopoulos I; Kremer J; Zeiher AM; Schächinger V; Fichtlscherer S
    J Interv Cardiol; 2009 Aug; 22(4):311-9. PubMed ID: 19689656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of stents versus bypass surgery in diabetic and nondiabetic patients with multivessel or left main coronary artery disease: a pooled analysis of 5775 individual patient data.
    Park DW; Kim YH; Song HG; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Chung SH; Choo SJ; Chung CH; Lee JW; Park SJ
    Circ Cardiovasc Interv; 2012 Aug; 5(4):467-75. PubMed ID: 22872052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.
    Yates MT; Soppa GK; Valencia O; Jones S; Firoozi S; Jahangiri M
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):606-10. PubMed ID: 23402690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of stenting technique and bifurcation anatomy on long-term outcomes of PCI for distal unprotected left main coronary disease.
    Ng W; Lundstrom R; McNulty E
    J Invasive Cardiol; 2013 Jan; 25(1):23-7. PubMed ID: 23293171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
    Mack MJ; Head SJ; Holmes DR; Ståhle E; Feldman TE; Colombo A; Morice MC; Unger F; Erglis A; Stoler R; Dawkins KD; Serruys PW; Mohr FW; Kappetein AP
    JACC Cardiovasc Interv; 2013 Apr; 6(4):344-54. PubMed ID: 23523456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.